5 Comments
Nov 19Liked by Eric Topol

@Eric, Given the relatively low cost of sequencing, are there potential concerns for use of this information by health insurers to decline or alter coverage based on either running the the assay or discovering the information in the patient’s medical record? If so, are there any protective steps for the public to take?

Expand full comment
founding
Nov 19Liked by Eric Topol

An MD I visited not long ago proposed I get genetic testing. I had the sense that she was proposing this to all her patients, no matter their demographic (she had a flyer she was giving out to her patients). I am well into my golden years, with no offspring, so it didn’t make sense to me why she would propose it. For younger people, though, it definitely does seem worth considering. But this is all layperson conjecture, and it would be interesting to hear what you think about when it is most indicated to get this sort of testing.

Expand full comment

@Eric Which commercial sequencing companies reliably identify P/LP variants of the ACMG listed genes?

Expand full comment